Connection
David Raben to Retreatment
This is a "connection" page, showing publications David Raben has written about Retreatment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.021 |
|
|
|
-
Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen C. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1020-5.
Score: 0.021